SE vs. RIGL
SE (Sea Limited) and RIGL (Rigel Pharmaceuticals, Inc.) are both stocks. SE operates in Electronic Gaming & Multimedia (Communication Services), while RIGL operates in Biotechnology (Healthcare). Over the past 5 years, SE returned -17.31%/yr vs -1.65%/yr for RIGL. Their 0.23 correlation means their historical movements had little consistent relationship.
Performance
SE vs. RIGL - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SE achieves a -16.33% return, which is significantly lower than RIGL's -14.06% return.
SE
- 1D
- 0.47%
- 1M
- 4.31%
- 6M
- -8.37%
- YTD
- -16.33%
- 1Y
- -31.86%
- 3Y*
- 17.43%
- 5Y*
- -17.31%
- 10Y*
- —
- ALL TIME*
- 23.92%
RIGL
- 1D
- -3.28%
- 1M
- -3.87%
- 6M
- 5.59%
- YTD
- -14.06%
- 1Y
- 74.79%
- 3Y*
- 40.40%
- 5Y*
- -1.65%
- 10Y*
- 3.86%
- ALL TIME*
- -10.60%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $11.43M | $14.01M | $13.32M | |
| $416.43M | $503.28M | $427.19M |
SE vs. RIGL - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
SE Sea Limited | -16.33% | 20.24% | 161.98% | -22.16% | -76.74% | 12.39% | 394.90% | 255.30% | -15.08% | -17.97% |
RIGL Rigel Pharmaceuticals, Inc. | -14.06% | 154.64% | 16.00% | -3.33% | -43.40% | -24.29% | 63.55% | -6.96% | -40.72% | -2.27% |
Correlation
The correlation between SE and RIGL is 0.16, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.16 |
Correlation (3Y) Balances recent behavior with more history. | 0.15 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.22 |
Correlation (All Time) Calculated using the full available price history since Oct 20, 2017 | 0.23 |
Fundamentals
SE:
$64.08B
RIGL:
$681.06M
SE:
$2.53
RIGL:
$18.94
SE:
42.20
RIGL:
1.94
SE:
0.20
RIGL:
0.00
SE:
2.70
RIGL:
2.36
SE:
5.28
RIGL:
1.81
SE:
$25.19B
RIGL:
$299.77M
SE:
$11.15B
RIGL:
$279.95M
SE:
$2.33B
RIGL:
$125.80M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SE vs. RIGL — Risk / Return Rank
SE
RIGL
SE vs. RIGL - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Sea Limited (SE) and Rigel Pharmaceuticals, Inc. (RIGL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| SE | RIGL | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.70 | ||
| Sortino ratioReturn per unit of downside risk | -2.68 | ||
| Omega ratioGain probability vs. loss probability | 0.91 | 1.25 | -0.33 |
| Calmar ratioReturn relative to maximum drawdown | -0.53 | 1.50 | -2.03 |
| Martin ratioReturn relative to average drawdown | -0.79 | 2.51 | -3.30 |
Loading charts...
Drawdowns
SE vs. RIGL - Drawdown Comparison
The maximum SE drawdown since its inception was -90.51%, smaller than the maximum RIGL drawdown of -99.37%. Use the drawdown chart below to compare losses from any high point for SE and RIGL.
Loading charts...
Drawdown Indicators
| SE | RIGL | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -90.51% | -99.37% | +8.86% |
Max Drawdown (1Y)Largest decline over 1 year | -60.22% | -50.08% | -10.14% |
Max Drawdown (3Y)Largest decline over 3 years | -60.22% | -50.76% | -9.46% |
Max Drawdown (5Y)Largest decline over 5 years | -90.51% | -83.85% | -6.66% |
Max Drawdown (10Y)Largest decline over 10 years | — | -86.40% | — |
Current DrawdownCurrent decline from peak | -70.91% | -96.55% | +25.64% |
Average DrawdownAverage peak-to-trough decline | -44.53% | -90.93% | +46.40% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 40.54% | 29.86% | +10.68% |
Volatility
SE vs. RIGL - Volatility Comparison
The current volatility for Sea Limited (SE) is 11.04%, while Rigel Pharmaceuticals, Inc. (RIGL) has a volatility of 11.97%. This indicates that SE experiences smaller price fluctuations and is considered to be less risky than RIGL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SE | RIGL | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.04% | 11.97% | -0.93% |
Volatility (6M)Calculated over the trailing 6-month period | 39.24% | 34.77% | +4.47% |
Volatility (1Y)Calculated over the trailing 1-year period | 51.46% | 70.02% | -18.56% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 64.24% | 85.52% | -21.28% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 62.35% | 82.76% | -20.41% |
Dividends
SE vs. RIGL - Dividend Comparison
Neither SE nor RIGL has paid dividends to shareholders.
Financials
SE vs. RIGL - Financials Comparison
This section allows you to compare key financial metrics between Sea Limited and Rigel Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
SE vs. RIGL - Profitability Comparison
SE - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Sea Limited reported a gross profit of 3.15B and revenue of 7.10B. Therefore, the gross margin over that period was 44.3%.
RIGL - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Rigel Pharmaceuticals, Inc. reported a gross profit of 54.21M and revenue of 58.82M. Therefore, the gross margin over that period was 92.2%.
SE - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Sea Limited reported an operating income of 565.39M and revenue of 7.10B, resulting in an operating margin of 8.0%.
RIGL - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Rigel Pharmaceuticals, Inc. reported an operating income of 11.89M and revenue of 58.82M, resulting in an operating margin of 20.2%.
SE - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Sea Limited reported a net income of 427.94M and revenue of 7.10B, resulting in a net margin of 6.0%.
RIGL - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Rigel Pharmaceuticals, Inc. reported a net income of 8.65M and revenue of 58.82M, resulting in a net margin of 14.7%.
Frequently Asked Questions
SE and RIGL have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
RIGL has higher volatility (11.97%) compared to SE (11.04%). In terms of maximum drawdown, SE dropped -90.51% vs RIGL's -99.37%.
RIGL currently has the higher Sharpe Ratio (1.07 vs -0.62), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for SE and RIGL
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer